What's even better than publishing a paper with "Takoyaki" in the title? 🥟 Celebrating w. a takoyaki party 😋. Congrats to lead author (and head chef) Sunho Lee et al. Takoyaki ultrasound enables real time 3D imaging of cells and molecules. nature.com/articles/s41467-0…

Check out our new article in @RadioGraphics Education Corner! ⬇️⬇️⬇️ Practical resource for #RadRes, particularly incoming R1s preparing for their first tumor board presentation

A reflection on oncology, literature, an the ways books can accompany patients and doctors through illness and hospital life. 📚📖 academic.oup.com/oncolo/arti…

RT @Gabe__MD: For two years I have heard that we need specialized, medically-tuned models for clinical decision support. That frontier mode…

💫 The Prostate Imaging Standards for Screening Magnetic Resonance Imaging (#PRISM): International Consensus Recommendations have just been published in @JAMAOnc 📄 Read the Special Communication here: jamanetwork.com/journals/jam… @NikhilMayor @LondonProstate1

Men's Health Month Spotlight: Prostate Cancer Imaging Explore this case-based series to strengthen your understanding of prostate cancer PET interpretation, compare the clinical applications of PSMA PET imaging agents, and enhance reporting practices that help guide patient care. ✔️ Small Volume, Single Lesion, Single Organ Metastatic Disease ✔️ Integrated Approach to PSMA PET with Multiparametric MRI of the Prostate ✔️ Benign Mimics & Physiologic Uptake on PSMA PET ✔️ PSMA PET in Biochemical Recurrence Access the whole series here for FREE: bit.ly/4uxr3nJ #PSMAPET #Radiology #CaseSeries #ProstateCancer #MolecularImaging #PETCT #RadEd #MedEd

🚨 PRIMARY2: PSMA-PET moves into the prostate cancer diagnostic pathway 📰Just out in @TheLancetOncol 🧬 660 biopsy-naïve pts w/ suspected significant PCa PI-RADS 3 MRI or PI-RADS 2 MRI w/ high-risk clinical features ⚖️Randomized to [⁶⁸Ga]Ga-PSMA-11 PET-CT vs systematic transperineal biopsy. 🧭 PRIMARY score 1–2 → surveillance. PRIMARY score 3–5 → PSMA-targeted biopsy. 🎯 PSMA-PET triage was non-inferior for clinically significant PCa detection: 12% vs 16% ✂️ Nearly half avoided biopsy: 49% (163/331). 📉 Clinically insignificant cancer detection dropped substantially: 14% vs 32%. ⚖️ Big implication: fewer biopsies less overdiagnosis, without losing significant cancers. 💡Caveat: follow-up ongoing; health economics validation w/ other PSMA tracers needed 🔗shorturl.at/RWxr7 @PCFnews @PCF_Science @renalandurology @UrologyTimes @urotoday

Dr. Bahl and colleagues analyzed 119K screening digital breast tomosynthesis exams, finding no change in cancer detection rate after implementing AI-based slab reconstruction, though the abnormal interpretation rate decreased and specificity increased. bit.ly/4ecx82u

The physician of tomorrow must be a clinician, an innovator & a systems thinker. Become that w/the Leadership in Radiology & Public Health Fellowship at Yale. This is a dual position as @YaleSPH MPH Candidate & @YaleMed Diagnostic Radiology Clinical Fellow bit.ly/3RTrc7m

What an honor to share the future #LIRADS with the wonderful @EsgarSociety audience!

picture this 8 of the world's biggest problems getting solved in the next 12-18 months 1. obesity: retatrutide phase 3 confirmed 30% bodyweight lost. 65% of patients no longer clinically obese. FDA submission late 2026 2. testosterone decline: FDA is expanding testosterone therapy. peptide and endocrine protocols going mainstream. the 1970 baseline is coming back. 3. birth rate crisis: embryo optimization commercially available today. scientists just rejuvenated aging human eggs in the lab. fertility is soon no longer a countdown 4. aging: Life Biosciences just injected the first reverse-aging drug into a human. Sinclair's oral reprogramming pill entering XPRIZE trials. 5. Alzheimer's: Retro Biosciences dosed the first humans with a pill that reactivates the brain's cellular cleanup machinery. Phase 1 results Q3 2026. 6. cancer: daraxonrasib nearly doubled survival in pancreatic cancer. RAS has been undruggable for 40 years. they drugged it. 7. mental health: psychedelics got a presidential executive order. Compass weeks from the first FDA approval of psilocybin. 8. heart disease: inflammation replacing cholesterol as the primary target. the root cause is finally being treated not the symptom. every single one of these has a clinical trial or an FDA action behind it right now humanity is slowly healing bio/acc

The 1st @YaleBioImaging continues until 5 PM at @YaleMed. In photos clockwise from top left, Brian Smith, Chair of @Yale_LabMed welcomes guests; Institute Director Georges El Fakhri introduces keynote speaker Bruce Tromberg, PhD, Director of @NIBIBgov; Dr. Tromberg; guests.

Proud moment for our lab at #SIIM26! 🎉 Congratulations to our wonderful PI, Dr. @Slowvak, on receiving the Dr. Joe Gitlin Award, and to Dr. @BrdKhsrv on receiving the Early Career Award.

What does the ABR alternate certification pathway mean for the future of radiology? This story explores its promise, practical barriers and the role it could play in strengthening the U.S. radiology workforce. Read more now. bit.ly/4xpEOaD @adarshghost @S_AfshariMirak @inasMohamed_md #ImagingProfessionals #RadiologyWorkforce

1/8 Can MRI contrast selection alter post-treatment tracking in #HCC? New @radiology_rsna study pits ECA vs HBA agents head-to-head using #LIRADS Nonradiation Treatment Response Algorithm v2024 to find out which catches viable #HCC best!  #RadInTraining #Tweetorial @RITEditor

New federal support is accelerating focused ultrasound innovation. @ARPA_H recently announced funding support for two new focused ultrasound projects: one led by Attune Neuro to advance neuromodulation for chronic pain and depression, and another led by the @SalkInstitute to accelerate sonogenetics toward human clinical trials. These investments reflect the increasing recognition among federal funders of focused ultrasound as a versatile, noninvasive platform technology with the potential to address unmet needs for brain disorders and chronic conditions. Learn more: ow.ly/vc5a50Zae05

Pancreatic solid pseudopapillary neoplasms in male patients exhibit different clinical and imaging features compared with those in female patients link.springer.com/article/10… Kozuki et al #abdrad #radres #radiology #FOAMrad @RadGeek @LetDdiceFlyHigh @ClinMedJournals @SocietyAbdRad

Drs. Ma and Zhao present a rare case of ossifying thymoma, defined by osseous metaplasia in varying distributions, with accompanying CT and volume-rendered images. bit.ly/3RYuUMW

@mightyasp and @RuchikaTalwarMD discuss the operational realities of urologic oncology, implementing NMIBC workflows, and how modern surgeons use video "game tape" to prep for complex cases. Tune in to the latest episode: backtable.com/shows/industry… #Urology #MedEd #IND101

Join us in congratulating the latest @VanderbiltU and @VUMChealth Innovation Catalyst Fund Awardees 👏 Learn more about the faculty awardees and their projects addressing critical challenges through translational research: cttc.co/article/20260610/inn…